Business Context and Reporting Period
This Form 6-K filing by Quantum Biopharma Ltd. (formerly FSD Pharma Inc.) covers the month of August 2024, with a specific reporting date of August 15, 2024. The company is a foreign private issuer headquartered in Toronto, Ontario, Canada.
Key Financial Metrics
The filing text does not provide a clear value for revenue, profit, cash flow, margins, debt, or liquidity. This report is a corporate governance filing regarding structural changes rather than a financial results report.
Material Changes
- Corporate Name Change: The registrant changed its name from "FSD Pharma Inc." to "Quantum BioPharma Ltd."
- Reverse Stock Split: The company effectuated a one-for-sixty-five reverse stock split of its Class A Multiple Voting Shares and Class B Subordinating Voting Shares.
- Regulatory Filing: These changes were formalized via a Certificate of Amendment and Articles of Amendment issued by the Ontario Ministry of Public and Business Service Delivery on August 15, 2024.
Guidance, Outlook, and Risks
The filing text does not provide a clear value for financial guidance, management commentary on future outlook, specific risks, contingencies, or unusual items. The document focuses solely on the legal execution of the name change and stock split.
Investor Verification Checklist
- Verify the post-split share count and trading symbol updates on major exchanges.
- Confirm the effective date of the name change for all regulatory and trading platforms.
- Review the attached Exhibit 3.1 (Certificate of Amendment) for specific details on the share class restructuring.
- Check subsequent filings for the first financial report reflecting the new capital structure.